Techniques like ion-pairing reversed-phase liquid chromatography (IP-RPLC) are widely used to monitor peptide critical quality attributes (CQAs), with hyphenated LC-MS approaches playing a key role in enhancing sensitivity and selectivity, enabling quantification of low-level impurities
bioequivalence is concluded if certain criteria are met, including, but not limited to, the ratio of these pharmacokinetic (PK) parameters between the test and reference formulations falling between prespecified criteria with a certain assurance, which vary by each respective guideline [28,29,30]
Standard-dose protocols are usually the better fit when the patients primary goal is significant weight reduction and they are comfortable with a more traditional titration plan
PlexusDx uses genetic and biomarker insights to contextualize these decisions within a personalized framework
So it's got to be lifestyle-driven but we're blunting the effect of that
